Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
R&D
Page 30
R&D
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
FDA orphan drug and rare pediatric disease designations granted to Arbor Biotechnologies’ primary hyperoxaluria type 1 treatment
Relmada Therapeutics acquires potential Tourette syndrome therapy from Asarina Pharma
Vanda Pharmaceuticals and AnaptysBio announce global license agreement for Generalized Pustular Psoriasis treatment
BioNTech and DualityBio form global strategic partnership to accelerate development of...
5th April 2023
Galapagos and NovAliX enter into drug discovery collaboration
4th April 2023
Agility Life Sciences forge Strategic Partnership with Solitek
28th March 2023
Predictive Oncology and Cancer Research Horizons partner to pursue development of...
17th March 2023
Aitia and UCB form strategic drug discovery collaboration in Huntington’s disease
17th March 2023
Revolutionary new bone cancer drug could save children’s lives
15th March 2023
ModeX Therapeutics enters into exclusive worldwide license and collaboration agreement with...
10th March 2023
Cancer Research UK signs multi-project collaboration with UCB to develop antibody...
9th March 2023
Caris Life Sciences enters into broad precision medicine partnership to advance...
9th March 2023
Confo Therapeutics signs global licensing agreement with Lilly for peripheral pain...
8th March 2023
1
...
29
30
31
...
54
Page 30 of 54
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...